Peregrine Pharma (PPHM) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts PPHM Hot Sheet
Price: $0.61 --0%
Financial Fact:
Research and development: 8.57M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Research and development: 8.57M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Peregrine Pharma (NASDAQ: PPHM) reported Q4 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $9.31 million versus the consensus estimate of $6.42 million.
For earnings history and earnings-related data on Peregrine Pharma (PPHM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- OMNIQ Corp. posts Q2 2026 revenue of $7.4M, widens net loss
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
